Current Introductory Content
Professional Aptitudes:
Report writing & documentation
Meticulous attention to detail
Effective verbal & written communication
Safe handling of chemical products
Chemical analysis & quality testing
Waste-treatment protocols
Methodical, organized workflow
Strict adherence to SOPs / protocols
Collaborative team leadership
Strong presentation & interpersonal skills
Compassionate patient-centric approach
Negotiation & conflict resolution
High-workload capacity & multi-tasking
Bilingual fluency (Spanish English)
Proactive
Multi task
1.- Generate Granular and Accurate Grant Plans:
· Independently create detailed and precise Grant Plans for Investigator Fees using an
Industry Benchmarking Tool.
· Develop plans by trial, country, and other protocol
variables for all Novartis- sponsored studies.
2.-Translate Clinical Protocols:
· Convert the clinical protocol visit schedule of assessments into intelligent Grant Plans (Investigator Fees) and Fair Market Value (FMV) cost estimations.
· Ensure clinical operational and scientific requirements are accurately reflected.
· Collaborate closely with the clinical team for accurate "Grant Plan specifications" to improve estimates and reduce revisions.
3.-Provide Clinical Operational Feedback:
· Offer feedback to Clinical Trial Teams on the impact of study protocol procedures, visit design, and other aspects affecting the overall study forecast.
· Analyze by procedure, visit, patient, and country.
4.-Collaborate with Global Clinical Teams:
· Work with Global Clinical Teams using clinical expertise to identify and define clinical and operational issues within the study protocol design.
· Assess the impact of amendments and operational changes on cost constraints and inefficiencies and provide recommendations.
· Supported regulatory submission activities to FDA and EMA, ensuring alignment of operational and financial documentation with regulatory expectations.
5.-Engage with Countries and Regions:
· Ensure mutual understanding between Headquarters and Countries about Grant Plan outputs, country specifics, regulations, and overall workload at trial sites.
· Improve the quality and acceptance of Grant Plan reports.
6.-Identify Productivity Savings and Cost Avoidance:
· Identify early productivity savings and cost avoidance opportunities, such as frequency of assessments, indication level assessment, and country costs.
· Identify potential risks and opportunities based on existing portfolio information and benchmarks to enhance the robustness and accuracy of cost estimations.
7.-Act as a Subject Matter Expert:
Support clinical trial teams with the development and understanding of Grant Plan and FMV assessments.
· Provide training and guidance to team members to enhance their knowledge and skills.
8.-Support in FMV Activities:
· Provide support in FMV activities for the following in-scope areas:
· Local, Regional, Global supported Third Party Sponsored (TPS) Investigator Initiated Trials (IITs).
Novartis Sponsored
Clinical trial management